top of page

F.A.Q.

clipart1771141.png

Frequently Asked Questions

F.A.Q.

10. Are there any contraindications or precautions for psychedelic-assisted therapy?

 

Yes, there are several contraindications and precautions to consider for psychedelic-assisted therapy. It's essential for trained professionals to thoroughly assess an individual's medical and psychological history to determine their suitability for this therapy. Here are some common contraindications and precautions:

1. Psychiatric Conditions: Individuals with a history of severe mental health conditions, such as schizophrenia, bipolar disorder, or active psychosis, are generally considered unsuitable for psychedelic-assisted therapy. Psychedelics can potentially exacerbate or trigger symptoms in these conditions.

2. Cardiovascular Conditions: People with significant cardiovascular issues, such as heart disease, uncontrolled high blood pressure, or a history of heart attacks or strokes, may be at increased risk during a psychedelic experience due to potential cardiovascular effects. It's crucial to consult with a healthcare professional to assess the safety of psychedelics in these cases.

3. Medications: Some medications, particularly monoamine oxidase inhibitors (MAOIs) and certain psychiatric medications, can interact negatively with psychedelics. It's important to disclose all medications being taken to healthcare professionals to evaluate potential interactions and contraindications.

4. Pregnancy and Breastfeeding: The safety of psychedelics during pregnancy and breastfeeding has not been sufficiently studied. Due to the potential risks to the developing fetus or infant, psychedelic-assisted therapy is generally contraindicated during pregnancy and breastfeeding.

5. Substance Abuse and Addiction: Individuals with a history of substance abuse or addiction may require special consideration. While psychedelics have shown potential in treating addiction, careful evaluation and monitoring are necessary to ensure the therapy is appropriate and safe for individuals with a history of substance abuse.

6. Personal Readiness: Psychological readiness and stability are crucial for engaging in psychedelic-assisted therapy. Individuals who are currently experiencing significant emotional distress, are in a crisis, or lack the necessary support system may not be suitable candidates for this therapy at that particular time.

7. Age: The use of psychedelics in adolescents and young children is not well-studied, and the potential risks and benefits for this population are still being evaluated. Psychedelic-assisted therapy is typically conducted with adult individuals, and specific guidelines should be followed for age-appropriate therapy.

It is important for individuals to have a comprehensive medical and psychological screening by trained professionals before engaging in psychedelic-assisted therapy. These professionals can assess the suitability and safety of this therapy based on an individual's specific circumstances and provide appropriate guidance.

bottom of page